Nexentis Technologies Inc Com Par $0.0001 (New) 2025 (NXTS:NASDAQ) closed at $0.531 on November 2, 2026, down 9.21% on the day. The stock trades 97.8% below its 52-week high of $24.15 and 5.2% above its 52-week low of $0.505. Over the past year, it lost 97.6%. Nexentis Technologies Inc Com Par $0.0001 (New) 2025 is part of the Health Care sector.
In 252 trading sessions since October 31, 2025, NXTS closed higher on 86 days (34%). Its best day was June 22, 2026 (+155.91%) and its worst was June 23, 2026 (-55.31%). The stock moved 10% or more in a single session 39 times. It opened at least 5% above the previous day's high 6 times.
N2OFF owns 100% of MitoCareX Bio Ltd, a drug delivery company engaged in drug discovery targeting cancer therapeutics and other diseases through the mitochondrial SLC25 protein family. Additionally, N2OFF adopted an investment strategy focused on European renewable energy assets utilizing a RTB (Ready to Build ) business model. The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd. N2OFF also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatment technologies designed to reduce pathogen contamination in fruits and vegetables.
Find more stocks like NXTS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.